Daiichi Floxin otic will be launched in mid-February; product inaugurates Daiichi self-marketing in U.S..

Executive Summary

DAIICHI FLOXIN OTIC WILL BE IN LAUNCHED MID-FEBRUARY, the company said following FDA approval of the ofloxacin otic solution Dec. 16. The product will be available in pharmacies by the end of January. Daiichi will promote the product with a 54-person sales force, double the size of the Japanese firm's existing team of U.S. sales representatives. Floxin otic will be co-promoted by Johnson & Johnson's Ortho McNeil and McNeil Consumer Products sales forces. Ortho McNeil markets oral and I.V. Floxin in the U.S.